HealthEquity Free Cash Flow 2014-2024 | HQY
HealthEquity annual/quarterly free cash flow history and growth rate from 2014 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- HealthEquity free cash flow for the quarter ending July 31, 2024 was 146.77, a year-over-year.
- HealthEquity free cash flow for the twelve months ending July 31, 2024 was , a year-over-year.
- HealthEquity annual free cash flow for 2024 was $0.2B, a 95.88% increase from 2023.
- HealthEquity annual free cash flow for 2023 was $0.102B, a 47.17% increase from 2022.
- HealthEquity annual free cash flow for 2022 was $0.069B, a 40.71% decline from 2021.
| HealthEquity Annual Free Cash Flow | |
|---|---|
| 2024 | 200.01 |
| 2023 | 102.11 |
| 2022 | 69.38 |
| 2021 | 117.03 |
| 2020 | 72.07 |
| 2019 | 99.58 |
| 2018 | 65.86 |
| 2017 | 32.92 |
| 2016 | 17.27 |
| 2015 | 6.91 |
| 2014 | 12.58 |
| 2013 | 9.03 |
| HealthEquity Quarterly Free Cash Flow | |
|---|---|
| 2024-07-31 | 146.77 |
| 2024-04-30 | 51.60 |
| 2024-01-31 | 200.01 |
| 2023-10-31 | 134.21 |
| 2023-07-31 | 89.26 |
| 2023-04-30 | 22.40 |
| 2023-01-31 | 102.11 |
| 2022-10-31 | 56.88 |
| 2022-07-31 | 20.63 |
| 2022-04-30 | -7.71 |
| 2022-01-31 | 69.38 |
| 2021-10-31 | 34.12 |
| 2021-07-31 | 29.72 |
| 2021-04-30 | 12.96 |
| 2021-01-31 | 117.03 |
| 2020-10-31 | 72.09 |
| 2020-07-31 | 37.89 |
| 2020-04-30 | -4.26 |
| 2020-01-31 | 72.07 |
| 2019-10-31 | 51.66 |
| 2019-07-31 | 43.82 |
| 2019-04-30 | 18.71 |
| 2019-01-31 | 99.58 |
| 2018-10-31 | 69.97 |
| 2018-07-31 | 45.25 |
| 2018-04-30 | 19.49 |
| 2018-01-31 | 65.86 |
| 2017-10-31 | 50.85 |
| 2017-07-31 | 32.43 |
| 2017-04-30 | 11.41 |
| 2017-01-31 | 32.92 |
| 2016-10-31 | 21.53 |
| 2016-07-31 | 10.33 |
| 2016-04-30 | -0.21 |
| 2016-01-31 | 17.27 |
| 2015-10-31 | 12.13 |
| 2015-07-31 | 3.05 |
| 2015-04-30 | -0.51 |
| 2015-01-31 | 6.91 |
| 2014-10-31 | 4.25 |
| 2014-07-31 | 0.76 |
| 2014-04-30 | -0.73 |
| 2014-01-31 | |
| 2013-10-31 | 8.48 |
| 2013-07-31 | 4.72 |
| 2013-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $7.539B | $1.000B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $96.018B | 11.91 |
| Cencora (COR) | United States | $46.162B | 17.64 |
| DiDi Global (DIDIY) | China | $23.816B | 0.00 |
| ICON (ICLR) | Ireland | $18.182B | 16.19 |
| Natera (NTRA) | United States | $15.356B | 0.00 |
| Avantor (AVTR) | United States | $15.184B | 22.76 |
| Revvity (RVTY) | United States | $14.929B | 26.14 |
| Viatris (VTRS) | United States | $13.870B | 4.23 |
| BioMerieux (BMXMF) | France | $12.753B | 0.00 |
| Solventum (SOLV) | United States | $12.515B | 0.00 |
| CochLear (CHEOY) | Australia | $12.315B | 0.00 |
| Medpace Holdings (MEDP) | United States | $9.932B | 27.98 |
| Charles River Laboratories (CRL) | United States | $9.343B | 17.66 |
| Sonic Healthcare (SKHHY) | Australia | $8.376B | 0.00 |
| Doximity (DOCS) | United States | $7.863B | 49.82 |
| Bausch + Lomb (BLCO) | Canada | $7.221B | 33.62 |
| PACS (PACS) | United States | $6.544B | 0.00 |
| Life Times (LTH) | United States | $4.665B | 30.88 |
| Organon (OGN) | United States | $4.653B | 4.69 |
| Sotera Health (SHC) | United States | $4.492B | 22.66 |
| Surgery Partners (SGRY) | United States | $3.655B | 40.49 |
| BrightSpring Health Services (BTSG) | United States | $2.958B | 63.89 |
| Concentras Parent (CON) | United States | $2.542B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.527B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.482B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.349B | 88.43 |
| GeneDx Holdings (WGS) | United States | $2.094B | 0.00 |
| Premier (PINC) | United States | $2.032B | 9.14 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.922B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.586B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.402B | 7.04 |
| Progyny (PGNY) | United States | $1.354B | 23.81 |
| Pediatrix Medical (MD) | United States | $1.306B | 12.78 |
| Establishment Labs Holdings (ESTA) | $1.269B | 0.00 | |
| CareDx (CDNA) | United States | $1.194B | 0.00 |
| Agilon Health (AGL) | United States | $1.111B | 0.00 |
| Embecta (EMBC) | United States | $0.822B | 5.48 |
| InnovAge Holding (INNV) | United States | $0.803B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 0.00 |
| SBC Medicals (SBC) | United States | $0.707B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.505B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.470B | 0.00 |
| DocGo (DCGO) | United States | $0.371B | 13.96 |
| Enhabit (EHAB) | United States | $0.365B | 31.52 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.325B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.261B | 0.00 |
| ModivCare (MODV) | United States | $0.230B | 7.32 |
| Beauty Health (SKIN) | United States | $0.206B | 0.00 |
| Biodesix (BDSX) | United States | $0.189B | 0.00 |
| LifeMD (LFMD) | United States | $0.186B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.184B | 0.00 |
| MultiPlan (MPLN) | United States | $0.148B | 0.00 |
| Nutex Health (NUTX) | United States | $0.114B | 0.00 |
| So-Young (SY) | China | $0.089B | 21.53 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| OncoCyte (OCX) | United States | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.69 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.037B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.034B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.025B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |